LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
The FDA has approved the remote programming of cochlear implants via a telemedicine platform, freeing patients with severe to profound hearing loss from the need to visit specialized centers to get ...
The FDA has approved hearing implant maker Cochlear Limited’s submission for a new remote feature that would allow specialists to perform follow-up programming on a patient’s cochlear implant remotely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback